![Amer Zeidan: Being a fierce advocate for the patients](https://oncodaily.com/pub/uploads/2023/08/1517597352881-11111-e1691844049177.jpg)
Amer Zeidan: Being a fierce advocate for the patients
Amer Zeidan shared on X:
“There are many good qualities that an academic physician can be described with such as outstanding clinician, excellent educator, productive researcher, collaborative team player, phenomenal communicator etc but most important for me is being a fierce advocate for the patients..”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center.
Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023